Quick Answer
RELMADA THERAPEUTICS, INC. reported Earnings Per Share Diluted of $1.45 (loss) per share for the year ending 2025.
- RELMADA THERAPEUTICS, INC. showed an increase of +45.3% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from RELMADA THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on March 19, 2026.
- XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 5 years of available data (2021 to 2025), RELMADA THERAPEUTICS, INC.'s Earnings Per Share Diluted has grown by 79.7%.
- Historical annual values: Fiscal year 2025: $1.45 (loss) per share | Fiscal year 2024: $2.65 (loss) per share | Fiscal year 2023: $3.28 (loss) per share | Fiscal year 2022: $5.30 (loss) per share | Fiscal year 2021: $7.16 (loss) per share.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: